Amy R. Sood
About
In The Last Decade
Amy R. Sood
14 papers receiving 208 citations
Peers
Comparison fields: 5 of 56
- Cardiology and Cardiovascular Medicine 68
- Nephrology 66
- Pulmonary and Respiratory Medicine 62
- Epidemiology 48
- Pediatrics, Perinatology and Child Health 32
Countries citing papers authored by Amy R. Sood
This map shows the geographic impact of Amy R. Sood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy R. Sood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy R. Sood more than expected).
Fields of papers citing papers by Amy R. Sood
This network shows the impact of papers produced by Amy R. Sood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy R. Sood. The network helps show where Amy R. Sood may publish in the future.
Co-authorship network of co-authors of Amy R. Sood
This figure shows the co-authorship network connecting the top 25 collaborators of Amy R. Sood. A scholar is included among the top collaborators of Amy R. Sood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy R. Sood. Amy R. Sood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 18 | |
| 3 | Medication adherence in patients with chronic kidney disease. | 4 |
| 4 | Sodium thiosulfate, bisphosphonates, and cinacalcet for calciphylaxis. | 7 |
| 5 | 45 | |
| 6 | 17 | |
| 7 | 15 | |
| 8 | Update on the new Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for mineral and bone disorders (MBD)--a focus on medications. | 1 |
| 9 | Establishing and funding renal clinical pharmacy services. | 6 |
| 10 | Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medications. | 1 |
| 11 | Treatment of hyperkalemia in patients with chronic kidney disease--a focus on medications. | 4 |
| 12 | 13 | |
| 13 | 35 | |
| 14 | 33 | |
| 15 | 18 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.